India pesticides Limited has received in-principle approval from BSE Limited for listing equity shares under its Employee Stock Option Plan 2023. The approval, dated January 12, 2026, marks a significant step in the company's employee benefit initiatives, enabling stock option exercises for eligible employees.

BSE Approval Details

BSE Limited granted the approval through reference number DCS/ESOP/IP/TS/3998/2025-26 on January 12, 2026. The approval covers the following specifications:

Compliance Conditions

The BSE approval comes with several mandatory compliance conditions that India Pesticides Limited must fulfill. The exchange has outlined specific requirements including notification under Regulation 10(c) of SEBI regulations after share allotment, payment of prescribed fees, and receipt of all statutory approvals from authorities including SEBI, RBI, and MCA.

Additional compliance requirements include:

• Adherence to all exchange guidelines and statutory authority directions
• Compliance with listing agreement conditions
• Fulfillment of Companies Act 2013 and other applicable laws
• Submission of documents as per BSE checklist requirements

Regulatory Framework

The share allotment will be conducted under the Securities Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. BSE has reserved the right to withdraw its in-principle approval if any information submitted is found incomplete, incorrect, misleading, or false, or for any contravention of exchange rules and regulations.

The exchange will issue trading permission from time to time upon receipt of proper notifications and subject to compliance with all stated conditions. This approval enables India Pesticides Limited to proceed with its employee stock option plan implementation, providing eligible employees with equity participation opportunities in the company.

India pesticides Limited has received in-principle approval from the National Stock Exchange of India Limited (NSE) for listing equity shares under its Employee Stock Option Plan 2023. The approval, dated January 12, 2026, marks a significant step in the company's employee incentive program implementation.

ESOP Share Details

The NSE approval covers the listing of up to a maximum of 28.79 lakh equity shares with specific parameters outlined below:

Regulatory Compliance Requirements

The NSE approval comes with mandatory compliance conditions that the company must fulfill before the actual listing of shares. These conditions ensure adherence to regulatory frameworks and protect investor interests.

Key compliance requirements include:

• Notification to NSE under Regulation 10(c) after allotment and credit to beneficiary accounts
• Receipt of all statutory approvals from SEBI, RBI, and MCA
• Compliance with SEBI LODR Regulations 2015
• Adherence to Companies Act provisions
• Submission of required documentation as per NSE guidelines

Documentation and Process Framework

The approval process requires comprehensive documentation to ensure transparency and regulatory compliance. Essential documents include certified copies of board resolutions, allotment statements, and beneficiary details.

Specific documentation requirements encompass:

• Statement under Regulation 10(c) as per SEBI format
• NSDL/CDSL credit confirmation from registrar and transfer agent
• Board resolution for share allotment
• Complete list of allottees with share allocation details
• Details of employees receiving options exceeding specified thresholds

Regulatory Framework and Oversight

The approval falls under SEBI (Share Based Employee Benefits) Regulations, 2014, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. NSE retains the right to withdraw approval if submitted information proves incomplete, incorrect, or misleading.

The exchange emphasized that final listing and trading approval will be subject to complete compliance with all stated conditions. This framework ensures that employee stock option plans maintain transparency and adhere to established market regulations.

The company has informed both BSE and NSE about this development, with the information also made available on its official website for stakeholder access.